Seattle Genetics Shares Outstanding 2006-2019 | SGEN

Seattle Genetics shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Seattle Genetics shares outstanding for the quarter ending June 30, 2019 were 0.161B, a 1.19% decline year-over-year.
  • Seattle Genetics 2018 shares outstanding were 0.158B, a 10.11% increase from 2017.
  • Seattle Genetics 2017 shares outstanding were 0.143B, a 1.73% increase from 2016.
  • Seattle Genetics 2016 shares outstanding were 0.141B, a 8.95% increase from 2015.
Seattle Genetics Annual Shares Outstanding
(Millions of Shares)
2018 158
2017 143
2016 141
2015 129
2014 123
2013 122
2012 118
2011 113
2010 101
2009 91
2008 79
2007 61
2006 49
2005 42
Seattle Genetics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 161
Q1 2019 161
Q4 2018 158
Q3 2018 159
Q2 2018 163
Q1 2018 152
Q4 2017 143
Q3 2017 148
Q2 2017 143
Q1 2017 142
Q4 2016 141
Q3 2016 141
Q2 2016 140
Q1 2016 140
Q4 2015 129
Q3 2015 128
Q2 2015 125
Q1 2015 124
Q4 2014 123
Q3 2014 124
Q2 2014 123
Q1 2014 123
Q4 2013 122
Q3 2013 122
Q2 2013 121
Q1 2013 120
Q4 2012 118
Q3 2012 118
Q2 2012 117
Q1 2012 116
Q4 2011 113
Q3 2011 115
Q2 2011 114
Q1 2011 109
Q4 2010 101
Q3 2010 101
Q2 2010 101
Q1 2010 103
Q4 2009 91
Q3 2009 93
Q2 2009 86
Q1 2009 84
Q4 2008 79
Q3 2008 80
Q2 2008 79
Q1 2008 76
Q4 2007 61
Q3 2007 66
Q2 2007 57
Q1 2007 55
Q4 2006 49
Q3 2006 51
Q2 2006 50
Q1 2006 42
Q4 2005 42
Q3 2005 42
Q2 2005 42
Q1 2005 42
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.808B $0.655B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.351B 13.94
Gilead Sciences (GILD) United States $79.964B 9.82
Celgene (CELG) United States $67.146B 10.39
Vertex Pharmaceuticals (VRTX) United States $47.536B 51.37
Biogen (BIIB) United States $42.733B 7.59
Illumina (ILMN) United States $42.067B 49.42
CSL (CSLLY) Australia $35.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.603B 14.80
Alexion Pharmaceuticals (ALXN) United States $24.856B 13.10
Incyte (INCY) United States $17.876B 52.61
Exact Sciences (EXAS) United States $15.515B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.729B 0.00
Genmab (GNMSF) Denmark $12.376B 62.91
Guardant Health (GH) United States $9.438B 0.00
Sarepta Therapeutics (SRPT) United States $9.289B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.973B 0.00
Galapagos (GLPG) Belgium $8.822B 0.00
QIAGEN (QGEN) Netherlands $7.800B 25.62
Bio-Techne Corp (TECH) United States $7.483B 51.72
BeiGene (BGNE) Cayman Islands $6.826B 0.00
Bluebird Bio (BLUE) United States $6.633B 0.00
Exelixis (EXEL) United States $6.579B 17.10
Amarin (AMRN) Ireland $5.412B 0.00
Horizon Pharma Public (HZNP) Ireland $5.034B 12.80
Ascendis Pharma (ASND) Denmark $4.822B 0.00
Repligen (RGEN) United States $4.774B 92.64
ARGENX SE-ADR (ARGX) Netherlands $4.379B 0.00
Moderna (MRNA) United States $4.345B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.278B 0.00
Blueprint Medicines (BPMC) United States $4.129B 0.00
China Biologic Products (CBPO) China $3.889B 24.27
Spark Therapeutics (ONCE) United States $3.871B 0.00
MorphoSys AG (MOR) Germany $3.793B 0.00
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Alkermes (ALKS) Ireland $3.402B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.384B 0.00
Immunomedics (IMMU) United States $2.868B 0.00
Genomic Health (GHDX) United States $2.783B 52.20
Arena Pharmaceuticals (ARNA) United States $2.776B 5.97
Amicus Therapeutics (FOLD) United States $2.640B 0.00
NeoGenomics (NEO) United States $2.621B 140.22
CRISPR Therapeutics AG (CRSP) Switzerland $2.599B 0.00
Medicines (MDCO) United States $2.596B 0.00
MyoKardia (MYOK) United States $2.487B 0.00
Acceleron Pharma (XLRN) United States $2.424B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Reata Pharmaceuticals (RETA) United States $2.280B 0.00
Emergent Biosolutions (EBS) United States $2.252B 33.84
UniQure (QURE) Netherlands $2.154B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.093B 0.00
Cambrex (CBM) United States $2.016B 25.49
Akcea Therapeutics (AKCA) United States $1.980B 0.00
Zai Lab (ZLAB) China $1.960B 0.00
Myriad Genetics (MYGN) United States $1.873B 19.65
Ligand Pharmaceuticals (LGND) United States $1.805B 22.82
Denali Therapeutics (DNLI) United States $1.740B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.673B 0.00
Insmed (INSM) United States $1.481B 0.00
RA PHARMCTL INC (RARX) United States $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
AnaptysBio (ANAB) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.317B 0.00
Sangamo Therapeutics (SGMO) United States $1.313B 0.00
Editas Medicine (EDIT) United States $1.270B 0.00
Epizyme (EPZM) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.214B 0.00
Athenex (ATNX) United States $1.190B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.186B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.182B 0.00
Innoviva (INVA) United States $1.162B 3.36
Zymeworks (ZYME) Canada $1.034B 0.00
Alector (ALEC) United States $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.982B 0.00
Twist Bioscience (TWST) United States $0.965B 0.00
Cara Therapeutics (CARA) United States $0.928B 0.00
Principia Biopharma (PRNB) United States $0.892B 465.13
Adverum Biotechnologies (ADVM) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.845B 0.00
ANI Pharmaceuticals (ANIP) United States $0.829B 13.85
ZIOPHARM Oncology Inc (ZIOP) United States $0.823B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.809B 29.21
Arvinas (ARVN) United States $0.806B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.802B 0.00
Codexis (CDXS) United States $0.781B 0.00
Cytokineticsorporated (CYTK) United States $0.778B 0.00
Anika Therapeutics (ANIK) United States $0.775B 27.42
Retrophin (RTRX) United States $0.765B 0.00
WAVE Life Sciences (WVE) Singapore $0.732B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
Vericel (VCEL) United States $0.720B 0.00
Stemline Therapeutics (STML) United States $0.670B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.666B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Zealand Pharma (ZEAL) Denmark $0.651B 7.55
Heska (HSKA) United States $0.569B 73.68
MiMedx (MDXG) United States $0.559B 0.00
DBV Technologies S.A (DBVT) France $0.542B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Cellectis S.A (CLLS) France $0.511B 0.00
Intra-Cellular Therapies (ITCI) United States $0.502B 0.00
Revance Therapeutics (RVNC) United States $0.500B 0.00
Precision BioSciences (DTIL) United States $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
CytomX Therapeutics (CTMX) United States $0.424B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Agenus (AGEN) United States $0.389B 0.00
PHARMA MAR SA (PHMMF) Spain $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
AC Immune SA (ACIU) Switzerland $0.363B 26.90
Gritstone Oncology (GRTS) United States $0.350B 0.00
Arcus Biosciences (RCUS) United States $0.338B 0.00
Kadmon Holdings (KDMN) United States $0.324B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Scholar Rock Holding (SRRK) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.312B 0.00
Prothena (PRTA) Ireland $0.309B 0.00
Clovis Oncology (CLVS) United States $0.306B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Sorrento Therapeutics (SRNE) United States $0.293B 0.00
PDL BioPharma (PDLI) United States $0.292B 7.53
Kindred Biosciences (KIN) United States $0.284B 0.00
Cel-Sci (CVM) United States $0.284B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.269B 0.00
Geron (GERN) United States $0.266B 0.00
Dynavax Technologies (DVAX) United States $0.260B 0.00
Cellular Biomedicine (CBMG) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.249B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.247B 0.00
ChromaDex (CDXC) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Pfenex (PFNX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.214B 8.17
Five Prime Therapeutics (FPRX) United States $0.214B 0.00
PHASEBIO PHARMA (PHAS) United States $0.212B 0.00
Prometic Life Sciences (PFSCF) Canada $0.210B 0.00
Seres Therapeutics (MCRB) United States $0.208B 0.00
MannKind (MNKD) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Compugen (CGEN) Israel $0.194B 0.00
CorMedix Inc (CRMD) United States $0.193B 0.00
Spero Therapeutics (SPRO) United States $0.189B 0.00
Novavax (NVAX) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.180B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
BioTime (LCTX) United States $0.154B 10.30
Enzo Biochem (ENZ) United States $0.153B 0.00
Cerecor (CERC) United States $0.151B 0.00
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Synlogic (SYBX) United States $0.146B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 5.62
Acorda Therapeutics (ACOR) United States $0.130B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.123B 0.00
Celyad SA (CYAD) Belgium $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.113B 0.00
Liquidia Technologies (LQDA) United States $0.112B 0.00
Aduro Biotech (ADRO) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
TOCAGEN INC (TOCA) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Verastem (VSTM) United States $0.095B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Catalyst Biosciences (CBIO) United States $0.083B 0.00
Menlo Therapeutics (MNLO) United States $0.082B 0.00
Trevena (TRVN) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
VBI Vaccines (VBIV) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Antibe Therapeutics (ATBPF) Canada $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 30.80
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.034B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.029B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.07
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00